
Senseonics Holdings SENS
€ 5.00
5.82%
Quartalsbericht 2026-Q1
hinzugefügt 07.05.2026
Senseonics Holdings Operativer Cashflow 2011-2026 | SENS
Operativer Cashflow Jährlich Senseonics Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -59.1 M | -60.5 M | -70.2 M | -66.3 M | -56.1 M | -67.4 M | -136 M | -90.8 M | -55.7 M | -38 M | -25.5 M | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -25.5 M | -136 M | -66 M |
Operativer Cashflow Vierteljährlich Senseonics Holdings
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -32 M | - | - | -16.1 M | - | - | - | -20.3 M | - | - | - | -19.8 M | - | -48.9 M | -34.3 M | -20.2 M | - | -44.3 M | -30.4 M | -16.3 M | - | -59.2 M | -45.8 M | -29 M | - | -101 M | -65.9 M | -30.2 M | - | -67.1 M | -40.4 M | -20.5 M | - | -39.4 M | -24.2 M | -11.6 M | - | -27.8 M | -17.4 M | - | - | -8.19 K | - | - | - | -5.58 K | -7.81 K | -5.58 K | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -5.58 K | -101 M | -30.8 M |
Operativer Cashflow anderer Aktien in der Diagnostik & Forschung
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
-478 M | $ 18.56 | 10.74 % | $ 196 M | ||
|
Agilent Technologies
A
|
1.48 B | - | - | $ 34.4 B | ||
|
Castle Biosciences
CSTL
|
64.3 M | $ 18.88 | 4.02 % | $ 547 M | ||
|
Fulgent Genetics
FLGT
|
21.1 M | $ 16.19 | 1.44 % | $ 490 M | ||
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M | ||
|
Interpace Biosciences
IDXG
|
5.83 M | $ 1.8 | -5.26 % | $ 7.96 M | ||
|
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | ||
|
CareDx, Inc
CDNA
|
42 M | $ 20.49 | -0.58 % | $ 1.09 B | ||
|
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | ||
|
Medpace Holdings
MEDP
|
713 M | $ 419.17 | -1.08 % | $ 12.1 B | ||
|
Check-Cap Ltd.
CHEK
|
-46 K | - | - | $ 9.42 M | ||
|
Lantheus Holdings
LNTH
|
390 M | - | - | $ 6.5 B | ||
|
Mettler-Toledo International
MTD
|
956 M | $ 1 041.91 | 1.75 % | $ 21.5 B | ||
|
Myriad Genetics
MYGN
|
1.8 M | $ 3.62 | -2.95 % | $ 335 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
-29.1 M | $ 1.63 | 1.87 % | $ 2.17 M | ||
|
NeoGenomics
NEO
|
5.23 M | $ 8.36 | 1.21 % | $ 1.07 B | ||
|
National Research Corporation
NRC
|
26.4 M | $ 18.93 | 1.39 % | $ 424 M | ||
|
Natera
NTRA
|
-432 M | $ 196.91 | 0.81 % | $ 19.4 B | ||
|
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
738 M | $ 159.12 | -2.29 % | $ 7.89 B | ||
|
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | ||
|
Personalis
PSNL
|
-74.9 M | $ 6.71 | 5.01 % | $ 599 M | ||
|
Guardant Health
GH
|
-185 M | $ 98.66 | 0.19 % | $ 12.4 B | ||
|
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
1.29 B | $ 117.09 | -0.25 % | $ 9.66 B | ||
|
Illumina
ILMN
|
837 M | $ 143.24 | -1.21 % | $ 22.8 B | ||
|
Soleno Therapeutics
SLNO
|
46.8 M | $ 52.99 | 0.08 % | $ 2.69 B | ||
|
Trinity Biotech plc
TRIB
|
-4.19 M | $ 0.58 | -1.08 % | $ 208 M | ||
|
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 52.95 | -2.65 % | $ 3.17 B | ||
|
Biomerica
BMRA
|
-3.84 M | $ 2.41 | 7.11 % | $ 5.54 M | ||
|
Thermo Fisher Scientific
TMO
|
7.82 B | $ 448.21 | 0.49 % | $ 169 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 254.02 | -0.16 % | $ 21.1 B | ||
|
Waters Corporation
WAT
|
653 M | $ 333.21 | -0.51 % | $ 19.8 B | ||
|
Celcuity
CELC
|
-153 M | $ 134.72 | 8.23 % | $ 6.3 B | ||
|
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
58.2 M | $ 8.43 | -2.99 % | $ 1.83 B |